A detailed
mechanistic understanding of a benzylic photobromination
en route to belzutifan (MK-6482, a small molecule for the treatment
of renal cell carcinoma associated with von Hippel-Lindau syndrome)
has been achieved using in situ LED-NMR spectroscopy in conjunction
with kinetic analysis. Two distinct mechanisms of overbromination,
namely, the ionic and radical pathways, have been revealed by this
study. The behavior of the major reaction species, including reactants,
intermediates, products, and side products, has been elucidated. Comprehensive
understanding of both pathways informed and enabled mitigation of
a major process risk: a sudden product decomposition. Detailed knowledge
of the processes occurring during the reaction and their potential
liabilities enabled the development of a robust photochemical continuous
flow process implemented for commercial manufacturing.